Taken together, these results indicated that the dysregulated expression of BC200/miR-150-5p/MYB was a frequent event in MDS and that this positive feedback loop potentially promoted the pathogenesis and development of MDS. The gene discussed is BCYRN1; the disease is myelodysplastic syndrome.